title: [Intravenously administered immunoglobulin first-choice remedy in autoimmune diseases?].
authors.forename: D A
authors.initials: DA
authors.lastname: Breems
authors.forename: P W
authors.initials: PW
authors.lastname: de Haas
authors.forename: F
authors.initials: F
authors.lastname: Visscher
authors.forename: L J
authors.initials: LJ
authors.lastname: Sabbe
authors.forename: H F
authors.initials: HF
authors.lastname: Busch
authors.forename: P A
authors.initials: PA
authors.lastname: van Doorn
mesh_terms: D001327:Autoimmune Diseases / Q000628:therapy*; D002648:Child; D003882:Dermatomyositis / Q000628:therapy*; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D011129:Polyradiculoneuropathy / Q000628:therapy
chemical_list: D016756:Immunoglobulins, Intravenous
vernacular_title: Is intraveneus toegediend immunoglobuline het middel van eerste keuze bij auto-immuunziekten?